Babacan, Nalan Akgul
Eroglu, Zeynep
Article History
First Online: 20 March 2020
Compliance with Ethical Standards
:
: Nalan Akgul Babacan declares that she has no conflict of interest.Zeynep Eroglu has received research funding from Novartis and has received compensation from Regeneron and ArrayBioPharma for participation on advisory boards.
: This article does not contain any studies with human or animal subjects performed by any of the authors.